Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06279195
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-13
Brief Title:
Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
Sponsor:
NorthShore University HealthSystem
Organization:
NorthShore University HealthSystem
Study Overview
Official Title:
Comprehensive Mechanistic Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The mechanisms underlying variable efficacy of Relugolix-Combination Therapy REL-CT in mitigating unexplained pelvic pain will be evaluated with uterine imaging techniques and quantitative sensory testing
Detailed Description:
The mechanisms underlying variable efficacy of Relugolix-Combination Therapy REL-CT in mitigating unexplained pelvic pain will be evaluated with real-time uterine imaging techniques and quantitative sensory testing Advanced MRI methodology enables the assessment of various uterine parameters including contractions peristalsis perfusion blood oxygenation and structural factors Importantly it is possible to temporally correlate these mechanisms with self-reported spontaneous menstrual cramping pain through real-time imaging
In the first aim of this proposal Aim 1 mechanisms underlying unexplained menstrual pain phenotypes linked to deficiencies in myometrial activity perfusion and oxygenation and evaluate the subsequent impact of REL-CT will be evaluated Aim 2 focuses on characterizing unexplained menstrual pain phenotypes associated with impairments in the central nervous system sensory functions and the effects of REL-CT Quantitative sensory testing methods will be used to comprehensively assesses peripheral central ascending central integrating and central descending nervous system components related to pelvic pain In the past this testing can identify central nervous system component pain that predicts the pain trajectory and corresponds with treatment outcomes
By analyzing the relationship between the variable effectiveness of REL-CT treatment to observed mechanisms in menstrual pain it may possible to identify specific unexplained pelvic pain phenotypes amenable to medical management Furthermore because that the precise mechanisms by which REL-CT alleviates menstrual pain in endometriosis remain incompletely understood a cohort of endometriosis patients will be also studied The overarching objective is to uncover the underlying mechanisms that advance the comprehension of menstrual pain biology and establish these mechanisms as phenotypic markers for treating REL-CT
In the first aim of this proposal Aim 1 mechanisms underlying unexplained menstrual pain phenotypes linked to deficiencies in myometrial activity perfusion and oxygenation and evaluate the subsequent impact of REL-CT will be evaluated Aim 2 focuses on characterizing unexplained menstrual pain phenotypes associated with impairments in the central nervous system sensory functions and the effects of REL-CT Quantitative sensory testing methods will be used to comprehensively assesses peripheral central ascending central integrating and central descending nervous system components related to pelvic pain In the past this testing can identify central nervous system component pain that predicts the pain trajectory and corresponds with treatment outcomes
By analyzing the relationship between the variable effectiveness of REL-CT treatment to observed mechanisms in menstrual pain it may possible to identify specific unexplained pelvic pain phenotypes amenable to medical management Furthermore because that the precise mechanisms by which REL-CT alleviates menstrual pain in endometriosis remain incompletely understood a cohort of endometriosis patients will be also studied The overarching objective is to uncover the underlying mechanisms that advance the comprehension of menstrual pain biology and establish these mechanisms as phenotypic markers for treating REL-CT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None